| Literature DB >> 28077626 |
Feng Ru Tang1, Weng Keong Loke2, Boo Cheong Khoo3.
Abstract
Animal experimental studies indicate that acute or chronic low-dose ionizing radiation (LDIR) (≤100 mSv) or low-dose-rate ionizing radiation (LDRIR) (<6 mSv/h) exposures may be harmful. It induces genetic and epigenetic changes and is associated with a range of physiological disturbances that includes altered immune system, abnormal brain development with resultant cognitive impairment, cataractogenesis, abnormal embryonic development, circulatory diseases, weight gain, premature menopause in female animals, tumorigenesis and shortened lifespan. Paternal or prenatal LDIR/LDRIR exposure is associated with reduced fertility and number of live fetuses, and transgenerational genomic aberrations. On the other hand, in some experimental studies, LDIR/LDRIR exposure has also been reported to bring about beneficial effects such as reduction in tumorigenesis, prolonged lifespan and enhanced fertility. The differences in reported effects of LDIR/LDRIR exposure are dependent on animal genetic background (susceptibility), age (prenatal or postnatal days), sex, nature of radiation exposure (i.e. acute, fractionated or chronic radiation exposure), type of radiation, combination of radiation with other toxic agents (such as smoking, pesticides or other chemical toxins) or animal experimental designs. In this review paper, we aimed to update radiation researchers and radiologists on the current progress achieved in understanding the LDIR/LDRIR-induced bionegative and biopositive effects reported in the various animal models. The roles played by a variety of molecules that are implicated in LDIR/LDRIR-induced health effects will be elaborated. The review will help in future investigations of LDIR/LDRIR-induced health effects by providing clues for designing improved animal research models in order to clarify the current controversial/contradictory findings from existing studies.Entities:
Keywords: animal model; bionegative and biopositive effect; low-dose or low-dose-rate irradiation; molecular mechanism
Mesh:
Year: 2017 PMID: 28077626 PMCID: PMC5439383 DOI: 10.1093/jrr/rrw120
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Low-dose radiation–induced genetic and epigenetic changes in animal models
| Animal strains | Radiation source | Age and dose | End-point from irradiation | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| Female mouse with pink-eyed unstable ( | X-rays | Prenatal exposure at 17.5 days from 10 mGy to 1 Gy | 6-day-old offspring | Increased black spots (melansome streaks) on the fur at 10 mGy | [ |
| Female mice | γ-rays | 10-wk-old with doses from 10 mGy to 1 Gy (dose rate: 0.64 Gy/m) | 1 h after irradiation | Increased induction of Trp53 at 10 mGy in spleen cells, suggesting no lower threshold for induction of Trp53 | [ |
| Male B6C3F1/HSD mice | γ-rays | 8- to 10-wk-old with 100 mGy (dose rate: 0.18 Gy/m | 30 min and 4 h after whole-body irradiation | Increased expression for Parp-2, Gas2, Pcna, Pdcd6, Grik5, Grin1 and Gria3; decreased expression for Bub3 in brain at 100 mGy | [ |
| C57/Bl mice (male and female) | X-rays | Fractionated exposure at500 mGy applied as 50 mGy per day (2 mGy/s) for 10 days, or acute exposure 500 mGy (dose rate: 0.12 Gy/m) | 2 h after irradiation | Global genome DNA methylation in the liver and muscle. There are sex- and tissue-specific differences in p16(INKa) promoter methylation upon LDR exposure. In male liver tissue, p16(INKa) promoter methylation was more pronounced than in female tissue. | [ |
| Decrease in histone H4-Lys20 trimethylation in the thymus, which was accompanied by a significant decrease in global DNA methylation as well as the accumulation of DNA damage. | [ | ||||
| pKZ1 mouse | X-rays | 1 μGy–2 Gyanimal age: not mentioned | 3 days after irradiation | >100 mGy or <0.01 mGy: induction of chromosomal inversions in spleen cells; 0.1–100 mGy: decrease of chromosomal inversions | [ |
| C57BL/6J plasmid-based | Proton radiation | 6–12-wk-old with100 mGy–4 Gy | 1 day to 16 weeks after irradiation | Increased mutant frequencies in brain tissue from 2 days to 8 weeks at 100 mGy | [ |
| Female B6.129S2-Trp53tm1Tyj/1x129×1/SvJ mouse | Positron emission tomography (PET) scans | 7–9-wk-oldwith 18F-FDG at 0–150 or γ-rays at 0–100 mGy | 24 and 43 h after irradiation | Irradiation doses to the bone marrow corresponding to 33.43 mGy and above for internal 18F-FDG exposure and to 25 mGy and above for external X-ray exposure induced significant increases in micronucleated reticulocyte formation in blood cells | [ |
| BALB/c and Spret/EiJ), and F1-backcross (F1Bx) | X-rays | 100 mGy | 6 h after irradiation | Significant low-dose-specific metabolic profiles | [ |
| Male CBA/H and C57BL/6 mouse | X-rays | 10–12-wk-old mice at 10 mGy–3.0 Gy | 24 h after irradiation | Chromosomal instability, higher levels of TGF-β1 and TNF-α | [ |
Low-dose radiation–induced carcinogenesis in animal models
| Animal strains | Radiation source | Age and dose | End-point from irradiation | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| Bitransgenic CCSP-rtTA/Ki-ras mouse | Multiple whole-body CT doses | 9-wk-old mice, fractionated whole-body exposures of 5, 15 or 25 mGy for 4 times + lung imaging exposures of 30 mGy at 3 and 6 months (with total lung doses of 80, 120 and 160 mGy). | 9 months afterirradiation | Fractionated low-dose CT-radiation–induced carcinogenesis in individuals expressing cancer susceptibility gene. Irradiated females had significantly more excess tumors than irradiated males. | [ |
| BALB/c and C57BL/6 | X-rays | 9-wk-old mice, fractionated whole-body exposures of 75 mGy (weekly for 4 weeks; dose rate: 0.196 Gy/m) | 4 h and 1 month after last exposure | Low-dose radiation modified mammary gland cancer outcome, and mammary gland responses were strongly influenced by genotype, | [ |
| Female BALB/c/An NBd mice | γ-rays | 12-wk-old mice with a total dose of 2 Gy, fractionated exposure of 100 mGy/daily for 20 days (dose rate: 0.35 Gy/m) | Life-span monitoring carcinogenesis till natural death | For lung adenocarcinomas and mammary adenocarcinomas, carcinogenesis is dependent upon the per fractionated low-dose radiation exposure | [ |
| BALB/c mice | γ-rays | >12-wk-old,0.1–5 Gy (dose rate: 0.35 Gy/m) | 3 days afterirradiation | TGF-beta may serve as a mediator of tissue response to low-dose ionizing radiation, and orchestrate tissue response to oxidative stress | [ |
| Female C57BL/6 and BALB/c mice | γ-rays | 6-wk-old,4 weekly exposures to 75 mGy | 4 or 10 h and 1 month after exposure | Low-dose radiation response, at least for a number of genes, is highly dependent on exposure context and genetic background. | [ |
| Genotyped repair-deficient ATM−/−, questionable repair-proficient ATM+/− and repair-proficient ATM+/+ mice, SCID (CB17/Icr-Prkdcscid/Rj) mice | γ-radiation | 6-wk-old,0.1 Gy or 0.1 Gy × 10, 0.1 Gy × 20, 0.1 Gy × 40 | 0.5 h or 72 h after irradiation at 0.1 Gy or 24 or 72 h after the last fractionated irradiations | Single or repeated irradiation with 0.1 Gy leads to the accumulation of persisting DNA damage foci in cortical neurons, and thus may adversely affect brain tissue and increase the risk of carcinogenesis | [ |
| Female A/J mice treated with 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK) | whole-body CT | 7-wk-old, irradiated 4 weekly doses of 0, 10, 30 or 50 mGy for total radiationdoses of 40 mGy | 8 months after last CT scan | Exposure of sensitive populations to CT radiation increased the risk of tumorigenesis. Antioxidants could prevent the long-term carcinogenic effects of low-dose radiation exposure | [ |
Low-dose radiation–induced developmental changes in the animal brain
| Animal strains | Radiation source | Age and dose | End-point from irradiation | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| Han:NMRI mice | X-rays | Gestational Day 13 with 100 mGy (dose rate: 0.59 Gy/m) | One day after, or postnatal Day 25 (P25) or P180 | Increased single-strand breaks (SSBs) content and mitochondrial (mt) biogenesis | [ |
| Male C57BL/6J mice | Proton | 8–10–wk-old with 10 mGy | 48 h–12 months | An acute decrease in cell division within the dentate gyrus of the hippocampus and a decrease in hippocampal ICAM-1 immunoreactivity at 1 month postirradiation | [ |
| B6C3F1 male mice | γ-rays | 8–10-wk-old with 100 mGy (dose rate: 0.64 Gy/m) | 4 h | Induced expression of Troponin T1 (Tnnt 1) in pyramidal neurons of cerebral cortex and hippocampus, and in Purkinje cells of cerebellum | [ |
| B6C3F1 male mice | γ-rays | 8–10-wk-old with 100 mGy(dose rate: 0.64 Gy/m) | 4 h | Activated nine neural signaling pathways in the mice showed a high degree of concordance in their transcriptional response with the aging human brain or the brain tissue from patients with Alzheimer's disease | [ |
| APP/PSEN1 mice | Silicon radiation | Young mice with 0.1 Gy | 3 months | Spatial learning ability was impaired | [ |
| C57BL/6J | 1H | 10-wk-old with 100 mGy 1H | 1 and 3 months | Novel object recognition was impaired, and newly born activated microglia were significantly elevated | [ |
| Thy1-EGFP transgene mice | Proton | 8-wk-old with 100 mGy (dose rate: 0.25 Gy/m) | 1 month | Significant reduction of immature dendritic spines of granule cells | [ |
Low-dose radiation–induced cataractogenesis
| Animal species and strains | Radiation source | Age and dose | End-point from irradiation | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| Wistar rat | γ-rays | Young rat with 0.1 Gy (dose rate: 1.25 Gy/m) | 24 h | Cataractogenic degeneration | [ |
| B6CF1 mouse | 56Fe | 3–4-month-old with 50 and 100 mGy | 16 months | Cytopathological changes, including micronucleation, interphase death, and meridional row disorganization, and a pronounced ‘focal’ loss of epithelial cytoarchitecture | [ |
| Columbia-Sherman albino rats | Neutron | 4-wk-old with 2, 10, 50 mGy | 102 wk | Cataractogenesis | [ |
| Columbia-Sherman albino rats | 40Ar Ions | 4-wk-old with 10, 50 mGy | Every 2–3 wk, within a period of 3 days, up to a post-irradiation time of 67 wk | Cataractogenesis | [ |
| B6CF1/An1 Mouse | Proton, 20Ne, 56Fe, 93Nb, 193La ions, 60Co, | 90–110 days with 100 mGy for Proton, 20Ne, 56Fe, 93Nb, 193La ions, 60Co, | 64 wk | Micronucleus frequency and meridional row disorganization | [ |
Prenatal low-dose radiation–induced malformations of embryos and fetuses in animal models
| Animal strains | Radiation source | Age and dose | End-point from irradiation | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| CF1 female Swiss mice | X-rays | Gestational Day 0.5 with 43.85 mGy (dose rate: 0.15 Gy/m) | Gestational Day 18.5 | The exposure caused 11% more deaths than the controls | [ |
| CF1 female Swiss mice | X-rays | After fertilization but before any cleavage movements with 50 mGy (dose rate: 0.0455 Gy/m). | At 6 and 24 h after irradiation | The first cleavage was delayed, and there was an increase from 2.5% in the controls to 20% in the number of abnormals, among the irradiated. | [ |
| F/A and NMRI mice | Pion- or X-irradiation | Gestational Day 8, 10 mGy | 5 days after exposure | A significant increase in the rate of abnormal fetuses | [ |
| Swiss albino mice | X-rays | Gestational Day 3.5, 6.5 and 11.5 at ~9 mGy (dose rate: 0.83 Gy/m). | Gestational Day 18 | Significant increase in prenatal mortality, increased incidence of retarded fetuses and a significant decrease in the fetal head size and brain weight | [ |
| γ-rays | Gestational Day 11.5, exposed to 50 mGy to 500 mGy (dose rate: 0.83 Gy/m). | Gestational Day 18 | Significant reduction in head size and brain weight, a linear dose response for these effects in the dose range of 50 mGy to 150 mGy. | [ | |
| BALB/c and CF1 mice | X-rays | 7 h after fertilization exposed to100, 500 and 1000 mGy (dose rate: 0.8 Gy/m) | Gestational Day 18 | frequency of malformed fetuses increased; dwarfism occurred in CF1 mice | [ |
| ICR mice | X-rays | Gestational Day 9.5 with 20 mGy (dose rate: 0.667 mGy/m) 4 h after the priming irradiation | Gestational Day 18.5 | Primary conditioning with low doses of radiation suppresses radiation-induced teratogenesis | [ |
| C57BL/6J mice | X-rays | Gestational Day 11 with priming low dose from X-rays at 50 or 300 mGy (dose rate: 0.33 Gy/m) on gestation Day 11 followed by high dose of 3.5 Gy 1 day after | Gestational Day 18 | The priming low dose of X-rays significantly reduced the occurrence of prenatal fetal death, malformation, and/or low body weight induced by the challenge high dose of radiation | [ |
Health effects of chronic low-dose/low-dose-rate radiation exposure in animal models
| Animal strains | Radiation source | Exposure period | End-point from irradiation | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| Holtzman rat | γ-rays | 20 mGy/23 h-day for 30 days, pre- and early post-natal exposure | 11 successive generations | 20 mGy given continuously for 11 generations had a cumulative hereditary effect resulting in a reduced number of individuals per litter | [ |
| Mongrel rat fetuses | γ-rays | A total of 50 mGy, given at 6.25 mGy (dose rate: 0.43 mGy/h) daily for 8 days during the prenatal days from 6th to 18th, | Day 18 of pregnancy | Deceleration of neuroblast migration into the primary cortex, increases in the absolute number of macroglial cells in all cellular zones of the developing cortex | [ |
| Adverse effects on the processes of stem cellproliferation in the tissues of the developing cortex; also increased the intensity of cell destruction proportionally to the radiation dose | [ | ||||
| Male and female C57/Bl mice | X-rays | 500 mGy applied as 50 mGy per day for 10 days (dose rate: 0.12 Gy/m) | 2 h after thelast treatment on Day 10 | Global genome DNA methylation in the mouse liver and muscle. In male liver tissue, p16(INKa) promoter methylation was more pronounced than in female tissue | [ |
| Male and female C57/BL6 mice (45-day-old) | X-rays | Fractionated whole-body application of 500 mGy, 50 mGy daily for 10 days (dose rate: 0.12 Gy/m) | 4 h after the last treatment on Day 10 | A significant decrease in global DNA methylation as well as the accumulation of DNA damage in the thymus | [ |
| Male Pzh:SFIS mice | X-rays | 8-wk-old, 50 or 100 mGy/per day for 40 days (dose rate: 0.20 Gy/m), irradiated male mice mated with female mice without irradiation | Pregnant Day 17 | Decreases in the number of live fetuses and induced dominant lethal mutations | [ |
| Bank vole | 137Cs, 134Cs, 106Ru,144Ce from Chernobyl accident | Over 22 animal generations in 10 year with <73 mGy | 2 wks; 1, 2, 3 and 4 months; and 1 and 1.5 years | The radiation exposure of the parental generations led to an accumulated pool of germline mutations and/or of epigenetic changes, which resulted in elevated levels of chromosome aberrations and in increased embryonic losses in later generations. | [ |
| Male and female B6C3F1 | γ-rays | From 8-wk-old for 400 days with a dose rate of 1 or 20 mGy/per day | Life span | Induced neoplasms and shortening of the life span | [ |
| Female B6C3F1 mice | γ-rays | 20 mGy/22 h/day for 400 days | 400 days after irradiation | Decreased tumor-specific immune response and enhanced tumorigenesis | [ |
Low-dose and low-dose-rate ionizing radiation induced a biopositive effect in the animals
| Human population group | Radiation source | Dose exposed | End-point biomarkers | End-point biomarker changes and types of cells monitored | References |
|---|---|---|---|---|---|
| Mice (male and female) | γ-rays | 4.3 mGy/22 h-day for 100 days | 3 successive generations | Increased litter size | [ |
| Rat | γ-rays | 28.8 mGy, at dose rate of 1.2 mGy/h on Day 21 of the postnatal development | Body mass | Development of rat pups was accelerated (body mass made up 121% of control) | [ |
| ICR Swiss mice (male) | X-rays | 50 to 150 mGy(dose rate: 0.2 Gy/m) | Behaviour and psychological stress | Whole-body irradiation suppressed mounting behavioural and psychological stress | [ |
| MRL-lpr/lpr mice carrying a deletion in the apoptosis-regulating | γ-rays | 0.35 or 1.2 mGy/h for 5 wks | Life span and immunological modifications | Chronic low-dose-rate γ irradiation prolonged the life span and induced immunological modifications, including a significant increase in CD4+ CD8+ T cells in the thymus and CD8+ T cells in the spleen and also by a significant decrease in CD3+ CD45R/B220+ cells and CD45R/B220+ CD40+ cells in the spleen | [ |
| C57BL/6, BALB/c, C3H/He, DBA/1, DBA/2 and CBA mice | γ-rays | γ radiation at 1.2 mGy/h for 1, 3, 5, 7, 9, 13 or 17 weeks | Immunological modifications | Increase in CD4+ T cells and CD8 molecule expression, decrease in CD40+ B cells. Increases of CD4+ T cells, CD40+ B cells and anti-SRBC antibody-producing cells by immunization were significantly enhanced by continuous low-dose-rate irradiation at 1.2 mGy/h. CD3- CD4+ T cells, representative of abnormal immune cells, | [ |
| C57BL/6 mice | γ-rays | γ radiation at 1.2 mGy/h for 450 days 35 days before high dose X irradiation | Thymic lymphoma | Low-dose-rate irradiation suppressed thymic lymphoma induction accompanied by immune activation | [ |
| C57BL/6 mice | γ-rays | γ radiation at 1.2 mGy/h for 5 wks before high-dose X irradiation at 1.8 Gy × 4 | Thymic lymphoma | A prolonged γ irradiation at 1 mGy/hr suppressed skin tumors induced by methylcholanthrene and delayed high-dose-radiation–induced thymic lymphomas in C57BL/6 mice. | [ |
| db/db mice | γ-rays | 0.94 mGy/h for 24 days | Type II diabetes | Continuous low-dose-rate γ irradiation ameliorated type II diabetes in db/db mice by maintaining insulin secretion | [ |
| db/db mice (female) | γ-rays | 0.94 mGy/h from 10 weeks of age throughout their lives | Life span, nephropathy and antioxidant activities | Continuous low-dose-rate radiation significantly increased life span in db/db mice, and increased the number of normal capillaries in glomeruli. Antioxidant activities of superoxide dismutase, catalase and glutathione were significantly increased in kidneys. It also ameliorated diabetic nephropathy and increased life span in db/db mice through the activation of renal antioxidants. | [ |
| Trp53+/− female mice | CT scan or PET scan at 10–12 mGy | 7–8- wk-old | Lifespan study of cancer development | Single CT scan significantly extends overall lifespan relative to controls | [ |
| ApoE−/− (B6.129P2-Apoe tm1lUnc/J) female mice | γ-rays | 25, 50, 100 mGy (dose rate: 1 mGy/m) at 2 or 8 months of age. Mice were euthanized and tissues collected either 3 or 6 months (exposed at 2 months) or 2 or 4 months after exposure | Progression of atherosclerosis | Low doses given at low dose rate at either early or late stage of diseases were protective, slowing the progression of the diseases | [ |
| X-rays | Gestational Day 4.5, 4–76 mGy | Upon weaning | Increased DNA methylation in male offspring, and epigenetic alterations resulting from LDIR play a role in radiation hormesis | [ | |
| Klotho mouse | γ-rays | 0.35 or 0.7 mGy/h γ radiation from 40 days after birth | Life span | Low-dose-rate ionizing radiation prolonged the lifespan of mice | [ |
| Kunming mice | X-ray | 75 mGy (dose rate: 12.5 mGy/m) whole-body X-ray radiation 6 h before S180 sarcoma cell implantation | Antitumor effect and hormesis in an erythrocyte system | Increased the anti-tumor ability of the organism and improved the erythrocyte immune function and the O2-carrying ability. | [ |